WADDILL WILLIAM D. sold 53.5% of their position (9K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $1.06M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001104659-26-077761
Director
Since Jun 2019
-9K
Net shares
Net seller
$1.06M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9K acquired · 18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9K
Price / share
$16.54
Trade value
$148.86K
% of position
115.0%
6/23/2026
7.83K→16.82K
Common Stock
Direct
Shares
−9K
Price / share
$117.94
Trade value
$1.06M
% of position
53.5%
6/23/2026
16.82K→7.83K
Total
Net shares
+0.00
Net value
-$912.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2026 | M · Option Exercise | +9K | $16.54 | $148.86K | 115.0% | 7.83K | 16.82K |
| Common Stock Direct | 6/23/2026 | S · Sale | −9K | $117.94 | $1.06M | 53.5% | 16.82K | 7.83K |
| Total | +0.00 | -$912.60K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
9K shares
Shares
−9K
Strike price
16.54
Held after
0.00
Exercisable
—
6/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock9K shares | 6/23/2026 | M · Option Exercise | −9K | 16.54 | — | 0.00 |